Requisite Capital Management’s AbbVie ABBV Stock Holding History

Requisite Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-876	Closed	-$200K	–	115
2025 Q4	$200K	Sell	876 -127	-13%	-$28.9K	0.04%	118
2025 Q3	$232K	Buy	+1,003	New	+$204K	0.04%	300
2023 Q2	–	Sell	-1,272	Closed	-$203K	–	75
2023 Q1	$203K	Buy	+1,272	New	+$194K	0.06%	59
2022 Q2	–	Sell	-5,215	Closed	-$845K	–	61
2022 Q1	$845K	Buy	5,215 +2,500	+92%	+$363K	0.26%	35
2021 Q4	$368K	Buy	+2,715	New	+$321K	0.11%	54

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Requisite Capital Management's ABBV Position: Q1 2026 in Review

Requisite Capital Management sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 876 shares — an estimated $200K sold.

Requisite Capital Management first reported a position in ABBV in Q4 2021 and held it in 5 quarters. The position peaked at $845K in Q1 2022. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Requisite Capital Management reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
Requisite Capital Management sold 876 AbbVie shares in Q1 2026, an estimated $200K.
Requisite Capital Management first reported a position in AbbVie in Q4 2021 and held it in 5 quarters.
Requisite Capital Management's AbbVie position peaked at $845K in Q1 2022.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Requisite Capital Management's 13F filing for Q1 2026, filed 14 May 2026.